Expanding the clinical and mutational spectrum of the Ehlers-Danlos syndrome, dermatosparaxis type.

Genet Med 2016 09 14;18(9):882-91. Epub 2016 Jan 14.

Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.

Purpose: The Ehlers-Danlos syndrome (EDS), dermatosparaxis type, is a recessively inherited connective tissue disorder caused by deficient activity of ADAMTS-2, an enzyme that cleaves the aminoterminal propeptide domain of types I, II, and III procollagen. Only 10 EDS dermatosparaxis patients have been reported, all presenting a recognizable phenotype with characteristic facial gestalt, extreme skin fragility and laxity, excessive bruising, and sometimes major complications due to visceral and vascular fragility.

Methods: We report on five new EDS dermatosparaxis patients and provide a comprehensive overview of the current knowledge of the natural history of this condition.

Results: We identified three novel homozygous loss-of-function mutations (c.2927_2928delCT, p.(Pro976Argfs*42); c.669_670dupG, p.(Pro224Argfs*24); and c.2751-2A>T) and one compound heterozygous mutation (c.2T>C, p.? and c.884_887delTGAA, p.(Met295Thrfs26*)) in ADAMTS2 in five patients from four unrelated families. Three of these displayed a phenotype that was strikingly milder than that of previously reported patients.

Conclusion: This study expands the clinical and molecular spectrum of the dermatosparaxis type of EDS to include a milder phenotypic variant and stresses the importance of good clinical criteria. To address this, we propose an updated set of criteria that accurately captures the multisystemic nature of the dermatosparaxis type of EDS.Genet Med 18 9, 882-891.

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2015.188DOI Listing
September 2016
87 Reads

Publication Analysis

Top Keywords

dermatosparaxis type
16
eds dermatosparaxis
12
dermatosparaxis patients
8
ehlers-danlos syndrome
8
dermatosparaxis
6
fragilitymethods report
4
report eds
4
current knowledge
4
include milder
4
clinical molecular
4
vascular fragilitymethods
4
molecular spectrum
4
patients provide
4
comprehensive overview
4
spectrum dermatosparaxis
4
type eds
4
provide comprehensive
4
overview current
4
visceral vascular
4
eds include
4

References

(Supplied by CrossRef)

P Beighton et al.
Am J Med Genet 1998

A Lenaers et al.
Eur J Biochem 1971

R Hanset et al.
J Hered 1974

M Fjolstad et al.
J Pathol 1974

KA Holbrook et al.
J Invest Dermatol 1980

DF Counts et al.
J Invest Dermatol 1980

KA Holbrook et al.
J Invest Dermatol 1982

LT Smith et al.
Am J Hum Genet 1992

BV Nusgens et al.
Nat Genet 1992

W Reardon et al.
Clin Dysmorphol 1995

A Fujimoto et al.
Am J Med Genet 1997

Similar Publications